SCHEMBL7005705

SCHEMBL7005705

CCOC(=O)c1[nH]c2cccc(Cc3cccc(OC)c3)c2c1-c1cccc(NC(=O)NC2CC2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.49
KMT2A Q03164 4/20 0.49
NPC1 O15118 3/20 0.49
RAB9A P51151 3/20 0.49
MEN1 O00255 3/20 0.49
SMN1; SMN2 Q16637 4/20 0.41
NPSR1 Q6W5P4 1/20 0.40
LMNA P02545 1/20 0.40
HPGD P15428 1/20 0.40
HTT P42858 1/20 0.40
KDM4E B2RXH2 1/20 0.40
USP2 O75604 1/20 0.40
GAA P10253 1/20 0.39
EPHX2 P34913 1/20 0.39
ALOX15 P16050 1/20 0.39
CCR3 P51677 2/20 0.38
TUBB4A P04350 1/20 0.38
TUBB P07437 1/20 0.38
TUBA3C P0DPH7 1/20 0.38
TUBA1B P68363 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7006743 0.81 TUBB4A (0.44) MAPTKMT2ANPC1RAB9AMEN1
SCHEMBL7004935 0.78 MAPT (0.44) MAPTKMT2ANPC1RAB9AMEN1
SCHEMBL7004694 0.75 MAPK14 (0.50) SMN1; SMN2KDM4E
SCHEMBL7006235 0.74 ALDH1A1 (0.43) MAPTKMT2ANPC1RAB9AMEN1
SCHEMBL7002629 0.74 GABRA1 (0.44) MAPTKMT2ANPC1RAB9AMEN1
SCHEMBL6858292 0.73 MAPT (0.49) MAPTKMT2ANPC1RAB9AMEN1
SCHEMBL7005707 0.73 MAPT (0.51) MAPTKMT2ANPC1RAB9AMEN1
SCHEMBL7005512 0.72 MAPK14 (0.47) MAPTKMT2AMEN1SMN1; SMN2LMNA
SCHEMBL7003912 0.72 LTB4R2 (0.43) MAPTKMT2ANPC1RAB9AMEN1
SCHEMBL9023953 0.71 HSD17B10 (0.49) MAPTKMT2AMEN1SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1341761-A1 SUBSTITUTED INDOLES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INDOLES AND THEIR USE AS PPAR-$g(g) BINDING AGENTS SMITHKLINE BEECHAM CORPORATION (US) 2003-09-10 EP disclosed
WO-2002030895-A1 SUBSTITUTED INDOLES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INDOLES AND THEIR USE AS PPAR-η BINDING AGENTS SMITHKLINE BEECHAM CORPORATION (US) 2002-04-18 WO disclosed